Elanco Animal Health Incorporated (ELAN)
USD 11.73
(-4.71%)
USD 11.73
(-4.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.41 Billion | 4.41 Billion | 4.76 Billion | 3.27 Billion | 3.07 Billion | 3.06 Billion |
| Cost of Revenue | 1.93 Billion | 1.91 Billion | 2.13 Billion | 1.66 Billion | 1.47 Billion | 1.57 Billion |
| Gross Profit | 2.48 Billion | 2.5 Billion | 2.63 Billion | 1.6 Billion | 1.6 Billion | 1.49 Billion |
| Operating Expenses | 1.61 Billion | 2.11 Billion | 2.32 Billion | 1.68 Billion | 1.23 Billion | 1.17 Billion |
| Selling, General and Administrative Expenses | 1.28 Billion | 1.26 Billion | 1.4 Billion | 996.6 Million | 760.2 Million | 735.2 Million |
| Research and Development Expenses | 327 Million | 321 Million | 369 Million | 327 Million | 270.1 Million | 246.6 Million |
| Other Expenses | - | 528 Million | 556 Million | 359.9 Million | 200.4 Million | -41.3 Million |
| Cost and Expenses | 4.09 Billion | 4.02 Billion | 4.46 Billion | 3.35 Billion | 2.7 Billion | 2.75 Billion |
| Operating Income | 326 Million | 358 Million | 297 Million | 101.5 Million | 342.6 Million | 313.8 Million |
| Interest Expense | 277 Million | 241 Million | 236 Million | 149.8 Million | 78.9 Million | 29.6 Million |
| Income Tax Expense | 36 Million | 8 Million | -95 Million | -111.9 Million | 10.3 Million | 27.6 Million |
| Earnings before Tax | -1.19 Billion | -66 Million | -567 Million | -672 Million | 78.2 Million | 114.1 Million |
| Net Income | -1.23 Billion | -74 Million | -472 Million | -560.1 Million | 67.9 Million | 86.5 Million |
| Earnings Per Share Basic | -2.50 | -0.15 | -0.97 | -1.27 | 0.18 | 0.28 |
| Earnings Per Share Diluted | -2.50 | -0.15 | -0.97 | -1.27 | 0.18 | 0.28 |
| Weighted Average Shares Outstanding | 492.3 Million | 488.3 Million | 487.2 Million | 441.4 Million | 369 Million | 313.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 492.3 Million | 488.3 Million | 487.2 Million | 441.4 Million | 370.3 Million | 313.7 Million |
| Gross Margin | 0.56 | 0.57 | 0.55 | 0.49 | 0.52 | 0.49 |
| EBIT Margin | -0.05 | 0.20 | 0.18 | 0.14 | 0.18 | 0.21 |
| Profit Margin | -0.28 | -0.02 | -0.10 | -0.17 | 0.02 | 0.03 |
| EBITDA | -224 Million | 866 Million | 409 Million | -76.8 Million | 471.6 Million | 439.7 Million |
| Earnings Before Tax Margin | 0.07 | 0.08 | 0.06 | 0.03 | 0.11 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.18 Billion | 1.2 Billion | 1.03 Billion | 4.41 Billion | 1.06 Billion | 1.05 Billion |
| Cost of Revenue | 626 Million | 515 Million | 516 Million | 1.93 Billion | 487 Million | 434 Million |
| Gross Profit | 558 Million | 690 Million | 519 Million | 2.48 Billion | 581 Million | 623 Million |
| Operating Expenses | 443 Million | 557 Million | 509 Million | 2.16 Billion | 539 Million | 570 Million |
| Selling, General and Administrative Expenses | 354 Million | 337 Million | 292 Million | - | 313 Million | 353 Million |
| Research and Development Expenses | 89 Million | 87 Million | 79 Million | - | 86 Million | 81 Million |
| Other Expenses | -2 Million | -9 Million | -34 Million | -75 Million | -9 Million | -23 Million |
| Cost and Expenses | 1.06 Billion | 1.07 Billion | 1.02 Billion | 4.09 Billion | 1.02 Billion | 1 Billion |
| Operating Income | 115 Million | 133 Million | -24 Million | 326 Million | 42 Million | 53 Million |
| Interest Expense | 65 Million | 66 Million | 67 Million | 277 Million | 72 Million | 74 Million |
| Income Tax Expense | 18 Million | -20 Million | 14 Million | 36 Million | -1 Million | 18 Million |
| Earnings before Tax | -32 Million | 12 Million | -127 Million | -1.19 Billion | -1.09 Billion | -79 Million |
| Net Income | -50 Million | 32 Million | -141 Million | -1.23 Billion | -1.09 Billion | -97 Million |
| Earnings Per Share Basic | -0.10 | 0.06 | -0.29 | - | -2.22 | -0.20 |
| Earnings Per Share Diluted | -0.10 | 0.06 | -0.29 | - | -2.22 | -0.20 |
| Weighted Average Shares Outstanding | 494.2 Million | 493.2 Million | 492.8 Million | 492.3 Million | 492.7 Million | 492.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 494.2 Million | 496 Million | 492.8 Million | 492.3 Million | 492.7 Million | 492.6 Million |
| Gross Margin | 0.47 | 0.57 | 0.50 | 0.56 | 0.54 | 0.59 |
| EBIT Margin | 0.23 | 0.24 | 0.14 | - | 0.16 | 0.16 |
| Profit Margin | -0.04 | 0.03 | -0.14 | -0.28 | -1.03 | -0.09 |
| EBITDA | 277 Million | 290 Million | 147 Million | - | 173 Million | 166 Million |
| Earnings Before Tax Margin | 0.10 | 0.11 | -0.02 | 0.07 | 0.04 | 0.05 |
A31
4071
ALLO
1551
ANIKINDS
OMH